P

Inventor

DAVENPORT ADAM JAMES

GB12 patents
⚠️ This page may combine multiple inventors who share the name “DAVENPORT ADAM JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BAYER AG

6 patents
US10174016B2Jan 8, 2019

1,3-thiazol-2-yl substituted benzamides

BAYER AG4 citations82
US11142523B2Oct 12, 2021

1,3-thiazol-2-yl substituted benzamides

BAYER AG2 citations71
US10472354B2Nov 12, 2019

1,3-thiazol-2-yl substituted benzamides

BAYER AG3 citations71
US10202369B2Feb 12, 2019

1,3-thiazol-2-yl substituted benzamides

BAYER AG4 citations71
US10183937B2Jan 22, 2019

1,3-thiazol-2-yl substituted benzamides

BAYER AG4 citations71
US11319324B2May 3, 2022

Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors

BAYER AG0 citations47

Bayer Pharma AG

2 patents
US12023319B2Jul 2, 2024

Carboxylic acid aromatic amides

Bayer Pharma AG0 citations59
US11905270B2Feb 20, 2024

Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor

Bayer Pharma AG1 citations58

DAVENPORT ADAM JAMES

2 patents
US8912176B2Dec 16, 2014

Azetidines as histamine H3 receptor antagonists

DAVENPORT ADAM JAMES0 citations32
US8691804B2Apr 8, 2014

Azetidines and cyclobutanes as histamine H3 receptor antagonists

DAVENPORT ADAM JAMES0 citations27

ONO PHARMACEUTICAL CO

1 patent
US10519105B2Dec 31, 2019

KCNQ2-5 channel activator

ONO PHARMACEUTICAL CO0 citations38

AMGEN INC

1 patent
US8349831B2Jan 8, 2013

Calcium receptor modulating agents

AMGEN INC0 citations36